Common Contracts
3 similar Common Stock Purchase Agreement contracts by Intellia Therapeutics, Inc., Braeburn Pharmaceuticals, Inc.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • January 27th, 2017 • Braeburn Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS COMMON STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of January 26, 2017, by and between Braeburn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Apple Tree Partners IV, L.P., a Cayman Islands exempted limited partnership (“Purchaser”).
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • April 27th, 2016 • Intellia Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
THIS COMMON STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of April 26, 2016, by and between Intellia Therapeutics, Inc., a Delaware corporation (the “Company”), and Regeneron Pharmaceuticals, Inc., a New York corporation (“Purchaser”).
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • April 27th, 2016 • Intellia Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
THIS COMMON STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of April 26, 2016, by and between Intellia Therapeutics, Inc., a Delaware corporation (the “Company”), and Novartis Institutes for Biomedical Research, Inc., a Delaware corporation (“Purchaser”).
